Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romosozumab vs Denosumab in Glucocorticoid-induced Osteoporosis
NCT04091243Phase 4Completed
- Sponsor
- Tuen Mun Hospital
- Start
- Jan 2021
- Primary completion
- Oct 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of romosozumab in glucocorticoid-induced osteoporosis (GIOP), sponsored by Tuen Mun Hospital. Started Jan 2021; status: completed.
02
Drugs
romosozumab
03
Conditions
glucocorticoid-induced osteoporosis (GIOP)
Beyond the preview
Go deeper on NCT04091243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04091243.